Serum β-endorphin level in patients with depression on fluvoxamine
- 1 March 1999
- journal article
- Published by Elsevier in Il Farmaco
- Vol. 54 (3) , 130-133
- https://doi.org/10.1016/s0014-827x(99)00005-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pharmacological Properties of 403U76, a New Chemical Class of 5-Hydroxytryptamine- and Noradrenaline-reuptake InhibitorJournal of Pharmacy and Pharmacology, 1995
- Adrenal Function in Major DepressionThe Endocrinologist, 1995
- Neuropeptides and psychopathologyJournal of Controlled Release, 1994
- Plasma levels of ß‐endorphin, cortisol, prolactin and growth hormone in depressed patientsActa Psychiatrica Scandinavica, 1988
- FluvoxamineDrugs, 1986
- β-Endorphin/β-Lipotropin Immunoreactivity in Endogenous DepressionArchives of General Psychiatry, 1986
- Four definitions of endogenous depression and the dexamethasone suppression testJournal of Affective Disorders, 1985
- The WHO Depression Scale RELATIONSHIP TO THE NEWCASTLE SCALESActa Psychiatrica Scandinavica, 1980
- Opiate-receptor mediated changes in monoamine synthesis in rat brainJournal of Pharmacy and Pharmacology, 1978
- FLUVOXAMINE, A SPECIFIC 5‐HYDROXYTRYPTAMINE UPTAKE INHIBITORBritish Journal of Pharmacology, 1977